Genetic and functional complexity of bulk tumor has become evident through rapid advances in sequencing technologies. As a unique integrated approach to characterizing tumor heterogeneity, we demonstrate the multifaceted capabilities of a novel nanofluidic platform to enable single-cell phenotypic and genetic profiling of ovarian cancer patient-derived tumor cells. This approach has enabled increased resolution of tumor cell phenotypic and genetic heterogeneity, providing a better understanding of underlying biological drivers of the disease. A range of CA-125 expression levels is observed within cells from individuals, demonstrating clonal diversity consistent with other phenotypic data. Further, TP53 mutation analysis demonstrates a sub-population of cells exhibiting high mutation frequency that likely drives downstream growth kinetics and protein expression. Finally, genomic data is orthogonally used to address clonal heterogeneity across ovarian tumors when compared to bulk sequencing, illustrating the potential for single-cell sequencing data integrated with cellular functional and growth data toward future therapeutic intervention.
INTRODUCTION
Single cell sequencing analysis is a rapidly emerging field that has only recently been applied to identifying the diverse cellular landscape that constitutes living tissue and new, innovative technological advances have enabled progress in this field. [1] [2] [3] This approach has great potential to reveal previously obscured complexity in a variety of heterogeneous biological systems, but presents technological challenges that are unique to the single cell vantage point. One hurdle that needs to be overcome in single cell sequencing is capturing single cells that are 1) of high enough quality to yield sequenceable material and 2) numerous enough to yield population-representative data.
Historically, laser dissection and FACS have been used to isolate single cells for sequencing. 4 Laser dissection provides user-directed specificity in target cell selection, but is highly limited in the number of cells (tens to hundreds) that can be isolated. FACS also offers marker-based specificity during selection and permits the isolation of hundreds or thousands of cells, but can be time consuming (often resulting in sample degradation) and requires labor-intensive downstream processing for sequencing. Droplet-based single cell sequencing methods are the most recent innovative approaches that facilitate the isolation and sequencing of large numbers (thousands) of single cells in a highly efficient manner. These methods combine single cell isolation (via Poisson loading of single cells into fluid droplets) with cell lysis. This approach is somewhat limited in scope as it does not permit real time selection of target cells and is destructive to cellular material. 5, 6 Moreover, Poisson encapsulation is inherently inefficient and throughput-reducing, resulting in mostly empty droplets. Throughput of single cell approaches has been greatly improved by the addition of cell barcodes for multiplexing 7 and microfluidics to improve capacity and handling efficiency. Platforms such as Chromium, ddSeq and C1 now combine microfluidic devices and cell barcoding to enable cDNA generation from hundreds to thousands of single cells at once.
Finally, as single cell sequencing technologies develop, investigators can ask increasingly challenging research questions that require integration of complex cellular phenotype data with sequencing data. Approaches such as CITE-seq, where markers for cellular protein expression are combined with Drop-seq based cell isolation and processing, have begun to address these challenges, allowing sequencing information to be linked to characterized cells. 8 However, the types of phenotypic data accessible by this method are currently limited to antibody-labeled surface protein expression and cannot include complex metrics such as growth kinetic or cellular function.
To our knowledge, this study demonstrates the first platform to support characterization linking phenotype to genotype at the single cell level across a culture system, which will enable a more thorough, integrated analysis of tumor heterogeneity, and could rapidly accelerate the development of precision oncology for many tumor types. For this study, we focus on high-grade serous ovarian cancer (HGSOC) as a model to demonstrate the key components of our approach in providing a potentially more sensitive means of characterizing tumor heterogeneity at single cell resolution.
The poor survival rate of ovarian cancer, the most lethal female gynecologic malignancy which will be diagnosed in almost 200,000 women worldwide this year, 9 remains relatively unchanged over the past four decades. 10 HGSOC will account for nearly 80% of deaths from this disease. Though complete clinical response to surgical debulking and platinum-based chemotherapy is initially observed, three out of four women will experience tumor recurrence and succumb to platinum-resistant disease within five years of initial presentation. 11 Recent progress in precision oncology suggests the ability to move beyond the currently stagnant universal treatment assumptions for HGSOC and towards a more personalized approach based on tumor genotyping to reveal optimal therapies. Treatment options can include traditional cytotoxic chemotherapeutics and targeted agents aimed at providing the greatest antitumor response while also improving survival and, ideally, maintaining a higher quality of life. One major limitation to delivering precision oncology in HGSOC, and other cancers, is the current inability to account for the degree of temporal and spatial heterogeneity present within tumors. 12 For example, patients with chronic lymphocytic leukemia who have detectable subclonal driver mutations prior to initial treatment had earlier recurrences and shorter survival times. 13 Similarly, quantitative assessments of intratumor heterogeneity in HGSOC may be predictive of survival following chemotherapy. 14 Drug treatment itself has also been shown to drive sub-clones into distinct tumor populations, as shown with acute myeloid leukemia 15 and multiple myeloma. 16 Continuing to analyze HGSOC tumors en masse or even from multiple slices is unlikely to identify adequately and describe driver mutations and actionable pathways with direct consequences on a tumor's response to treatment. 12, [17] [18] [19] For example, The Cancer Genome Atlas (TCGA) analysis of HGSOC has identified TP53 mutations as the predominant molecular feature of this disease, albeit with a relatively "long tail" of rare but potentially actionable mutations. 20 Other analyses of HGSOC tumors have also documented a high degree of intratumoral and spatial heterogeneity. 14, [21] [22] [23] [24] Unfortunately, currently available HGSOC functional assays from patient-derived materials may not appropriately model this clonal complexity. 25 This work presents proof-of-concept data that demonstrates the capabilities of a new nanofluidic cell analysis system to facilitate single cell manipulation, culture, assay and analysis, and test its application across multiple modalities.
We have chosen several representative cell types (including those derived from immunological and cancer lineages)
in addition to cells derived from HGSOC patient tumor biopsies to illustrate the flexibility of this approach. Relying on light-induced dielectrophoresis technology, we interrogate tumor heterogeneity using single tumor cell sorting with subsequent analysis of growth kinetics and protein expression, followed by single cell genetic profiling of HGSOC patient-derived tumor cell lines.
RESULTS

Single Cell Handling Technology Overview
All data were collected using a novel, flexible nanofluidic platform, (Berkeley Lights, Inc. (BLI)), for single cell and batched multicellular selection and manipulation using light-induced dielectrophoresis. This system (Beacon TM prototype platform) is overviewed in Figure 1A . The platform integrates mechanical, fluidic, electrical and optical modules, enabling single cell manipulation, culture and imaging with a micrometer level of precision. The primary strength of the system is the disposable nanofluidic device with 1350-3500 individual chambers (pens) depending on chip design, each capable of holding sub-nanoliter volume. The fluidics subsystem delivers media to the chip for cell culture or reagent delivery and an actuated needle automates import and export of cells from incubated well plates.
A 3-axis robotic stage enables imaging of the entire chip area at 4x or 10x magnification in both brightfield and fluorescent modes for orthogonal characterization of morphologic, functional, and biochemical events. White light combined with a digital micromirror device (DMD) array is used to structure desired patterns for light-actuated dielectrophoresis or fluorescent illumination. 
Cell import, penning and export
Using this platform, we are able to load, position, culture and export cells in a defined and trackable manner. Target cells are specifically placed into numbered pens, where their growth is characterized and the cells are phenotyped, prior to export from the platform into a tracked position of a well plate for further processing and sequencing. As an overview, cells are imported from an incubated well plate onto the nanofluidic chip and guided into pens using lightinduced OEP force. Cells can be placed into pens (as single or defined groups of cells) in a highly parallel fashion.
One key advantage of the nanofluidic chip design that enables simultaneous and independent interrogation of many different cells is the sequestration of pens from each other. Following cell import, the main channel is flushed to eliminate any unwanted cells in the fluidic path; cells in the pens are fluidically isolated from the channel but remain accessible to soluble factors from the bulk media by diffusion.
An example of a complex penning strategy is shown in Fig. 1A , in which a single OVCAR3 cell is positioned in a pen, followed by a single Jurkat cell (Fig. 1A left inset) . In this case, 31 images were acquired to cover the entire chip area and a sampling of 9 stitched images centrally located on this chip design is shown. A machine vision algorithm is used to identify cells based on their size and morphology, and desired cells were shepherded by OEP into target pens on the chip ( 
Rare cell detection and automated cell annotation
This approach can be easily adapted to facilitate universal or discriminate selection of cells based on morphology and fluorescence across a broad range of inputs, minimizing dependence on sample input criteria and can be especially useful where cells of the desired phenotype are rare relative to the total number of cells in a complex sample. Specifically, we have developed penning strategies that permit inputting cell suspensions as dense as 2x10 7 cells/mL, which translates to 50,000 cells loaded into the chip at once. By performing sequential importing, penning, and flushing cycles, we can robustly sample hundreds of thousands of cells. Further improvements to the instrument have enabled automation that increases this sampling capacity. The ability to locate and track cells precisely is critical for dynamic experimentation examining both cell growth and functional biology, and iterative processing could further enable applications such as identifying small numbers of circulating tumor cells in patient blood samples. As a case study, we demonstrated the ability to select as few as 1 bead in 100,000 cells for penning by fluorescence (Fig. 2) . We spiked known numbers of green fluorescent microspheres into a background of unstained Jurkat cells, loaded onto a nanofluidic chip and imaged by both brightfield and fluorescence ( Fig. 2A) . Using segmentation and intensity threshold image processing algorithms embedded in the system software, we were able to identify the number and X,Y-coordinates of cells and beads in each field of view (Fig. 2B ) and used this information to calculate bead concentration. Correlation analysis revealed a χ 2 =0.99 between the measured spiking ratio and the observed bead concentration (Fig. 2C) . 
Figure 3. Automated annotation of co-localized cancer and PBMCs. (A) Brightfield and fluorescent images of 4 representative pens that each contain a single cancer cell and PBMC as positioned via OEP. Each image is labeled with the channel(s) used for visualization as well as the fluorophore depicted (if applicable). The exposure time was 50 ms for brightfield, 60 ms for DAPI, 400 ms for FITC, and 750 ms for Texas Red. (B-C) Histograms showing the area-based diameters and average intensities of all cells on the chip as measured under brightfield and each fluorescent channel. These parameters were obtained via segmentation-and threshold-based image processing algorithms embedded in the system software. (D) A histogram showing the integrated intensity of all cells on the chip as measured under DAPI (corresponding to the Hoechst stain). (E) A scatter plot depicting the average intensity of all cells on the chip as measured under FITC and Texas Red (corresponding to the MitoTracker Green and Anti-CD8, PE-CF594 stains, respectively). Several distinct clusters or populations of cells are identified.
In order to track functional characteristics of individual cell populations over time, the experimental platform has integrated four fluorescent imaging channels and automated cell annotation pipelines to monitor stained cells throughout the course of an experiment. Fluorescent signals can be used to inform penning of cells or as a means to track phenotype. This capability is demonstrated in Fig 3A, in which we co-penned two different cell types, A2780
human ovarian cancer cells and peripheral blood mononuclear cells (PBMCs). We stained both cell types with DAPI, MitoTracker Green, and Anti-CD8, PE-CF594. Use of Anti-CD8 allowed discrimination of PBMC subpopulations, such as T cells, based on CD8 surface expression. Penned cells were imaged across the entire chip to extract size and fluorescent intensity measurements using the system software and demonstrate the existence of several distinct clusters of cells based on marker expression (Figs. 3B, C, D, E).
Characterization of cell growth
In addition to penning target cells and characterizing cellular phenotypes, cells can be cultured on-chip over the course of several days, which enables the isolation and expansion of cells of interest from polyclonal populations.
Here, murine OKT3 cells were penned using OEP and cultured for 4 days. Images were acquired every 120 min for 48 h and machine vision algorithms were used to generate cell counts at each time point that were plotted to characterize growth patterns in MatLab (MathWorks, Inc.).
Figure 4. Growth of OKT3 suspension cells cultured on chip. (A) Growth curves for 5 selected pens over 48 h (B) Time lapse of clone with fastest growth rate (top) and example of identified apoptotic pen (bottom). (C) Histogram of cell count at t=48 h. Total number of pens that had two or more cells is 620; 370 single cells failed to divide. Mean growth after 48 h: 8.8 cells. (D) Map of multiple OKT3 clones which are independently loaded on the nanofluidic chip and tracked -each sample is represented by a different colored circle and the size of the circle represents the number of cells present for each clone after 48 h. (E) Map of inset from panel (D).
The mean observed doubling time was 16 h over 48 h of growth with no detectable loss of cell viability -this is comparable to the observed 11-14 h doubling time of this cell line off-chip under standard culturing conditions. A range of growth rates are observed when individual single-cell derived clonal growth curves are plotted over time from the OKT3 cell line (Fig. 4A) . Individual pens and cell growth characteristics are shown in Figures 4B and 4C.
These data strongly suggested that manipulation by OEP does not impact the viability of cells, and that nutrient transport from the channels to the pens can support expected levels of cell growth over time.
The cell penning and tracking strategies described here can also be used to enable investigations with multiple cell populations -many different cell types (or clones) can be penned, grown and characterized on the same chip. 
Phenotypic analysis of ovarian cancer cells
A REMARK diagram summarizing the patient-derived cell lines used in this study is shown in Fig. 5 . 
Growth characteristics
In order to facilitate phenotypic comparison, multiple independent cell populations can be cultured on a single nanofluidic chip, as shown in Fig. 6 , where four ovarian cancer patient-derived tumor cell lines (PT217, PT290, PT317, and PT261) and immortalized OVCAR3 cells were grown in parallel (Fig. 6A shows the penning map for these cells, in addition to a brightfield image of cells after loading in one sample region). Cells were penned using OEP, cultured on-chip for six days with image acquisition every two hours, and counted using the platform's automated cell tracking and counting features (Fig. 6B) . From experimental iterations (n=9), we determined that a minimum of 6-10 cancer cells generally need to be penned together on day 1 for survival and growth, possibly due to the presence of cell-secreted factors in the local pen microenvironment. Interestingly, it appears that the cells begin to aggregate at days 2 and 3, eventually forming a multicellular spheroid that could be used for downstream diagnostic and/or prognostic experimentation ( Fig. 6C and inset) .
Notably, given consistent culture conditions across the chip, each independent cell population has a unique set of growth kinetics. Tumor cells derived from PT217, who had stage IV cancer and succumbed to her disease 9 months after initial surgery, demonstrated the most aggressive growth rate, while those derived from PT290, who is currently the longest survivor in this cohort and presented with stage III disease, showed the slowest growth kinetics (patients were ranked by growth rate in decreasing order as follows: PT217, PT261, PT317 and PT290). By adjusting pen geometry, media conditioning, or starting cell number, the microenvironment can be optimized to provide robust growth conditions for the target cells. In particular, these data highlight several unique features of our approach which are the ability to simultaneously: 1) culture and characterize single or groups of patient-derived cells, 2) culture multiple cell types or mixtures, and 3) track and compare growth kinetics of individual cells within these populations.
Single cell protein expression assays
The BLI platform also performs real-time monitoring of protein expression from independent cell populations over time with single cell resolution. In the context of ovarian cancer, the measurement of Cancer Antigen 125 (CA-125) levels is approved by the FDA as a proxy for monitoring ovarian cancer response to treatment and correlates with tumor burden. 26 As such, it was of interest to investigate the ability to detect and measure CA-125 secretion at the single cell or subclone population level. Cell surface CA-125 expression was clearly detected and compared by fluorescent labeling from the four primary cell cultures and the immortalized cell line which had been multiplexed and cultured for 6 days on a single chip (Fig. 6D) . A range of CA-125 expression levels was observed between patients and even among individual cells derived from a single patient, demonstrating the ability to monitor unique cell expression signatures over time. Co-localization analysis of multiple markers over time can be performed to assess biological function, as seen in Fig. 6D , which shows a high degree of overlap between Syto24 (a cell viability stain) and Anti-CA-125. highlighted that expression levels varied by as much as 250 percent in both inter-and intra-cloned cell populations.
While the approach described here targets cellular CA-125 expression rather than CA-125 serum levels, it is interesting to highlight the concordance of these two metrics in PT217, who was a chemoresistant, stage IV HGSOC patient. This patient showed a unique CA-125 single-cell expression profile (Fig. 6E) , which is distributed bimodally; these data suggest two distinct cellular subpopulations, including one with a high CA-125 expression level that is approximately double the other mean CA-125 values. Notably, PT217 also had, by over 3-fold, the highest CA-125 serum levels of all patients in this study (1578 U/mL versus 49 U/mL for PT261, 478 U/mL for PT290 and 187 U/mL for PT317).
In many cases, multiple phenotypic measures are needed to assess populations in cell culture, beyond just detection of a single protein marker. The heat map in Fig. 6F illustrates the integration of both growth and CA-125 expression.
Integration of the two biologic characteristics demonstrates the appreciated fact that CA-125 expression levels do not correlate with growth rates across all cell lines, with the one exception that PT217 (whose disease was the most progressed and who had the highest CA-125 serum levels as discussed above) had a subpopulation of cells with the highest CA-125 expression levels as well as the highest growth rate. cell (or indicated cell grouping) variant profiles demonstrating the ability to identify genetic subclonality of this patient sample while conserving the remainder of the sample for orthogonal processes either on-or off-chipfiltering criteria are described in detail in Methods. Using these variant profiles, 5 major subclones/subclades with significant variance were identified across 9 oncogenes from the tumor of this patient as shown in Fig. 7 and Table   3 . These data demonstrate the ability to use single cell genomics in tandem with the Beacon TM prototype platform to detect low-frequency clonal variation that would otherwise be masked by major variants from the bulk tissue (i.e., yellow and green clade), recapitulating that no major DNA damage affecting targeted sequencing has occurred in cells selected using OEP. When the single cell variant profiles are compared to those derived from the 10-, 100-and 1000-cell sub-batches, the increased sensitivity provided by single cell sequencing is apparent. The ability to perform high-resolution DNA sequencing from these cells clearly demonstrates the applicability and robustness of this platform, which selected for single cells or cell pools and resulted in successful genetic variant profiling of a primary cancer tissue biopsy. The sequencing QC metrics validate the successful library construction and sequencing metrics from single cells based on mean read depth, on-target read percentage, and uniformity, relative to the bulk metrics, which are 1263X, 97.5% and 75%, respectively. The functional implications of the variants detected in these cell groups could be addressed in a continuation of this study using a larger oncogenic cohort and single cells isolated by the experimental platform for genomic profiling.
DISCUSSION
In this publication, we demonstrate the multilayered and cross-functional phenotypic and genomic analysis of single cells made possible by the BLI Beacon TM prototype platform. Using HGSOC as our primary model, we aimed to identify the potential of this platform for use in developing novel experimental pipelines to facilitate precision medicine in many fields, including oncology. This novel cell analysis system provides a powerful new approach to unraveling the signaling networks controlling the evolution of HGSOC disease, and potentially those of many other tumor types and disease states. Together, this study has demonstrated the ability of the experimental platform to select single cells with high accuracy and position them precisely for subsequent analysis. Applications include single-or multi-cell isolation, investigation of cell-cell interactions, microenvironmental studies for single cells, groups of cells or spheroids, quantitation of cell growth, single-cell temporal phenotypic analysis and export for genomic interrogation. As the system continues to be developed, the addition of additional analysis pipelines is anticipated.
Using HGSOC as a relevant pathologic system, single cell isolation also allowed for precise genomic analysis and a more accurate estimation of subpopulation frequency and status (e.g., homozygous normal, heterozygous, homozygous variant) in the cells and tissues examined here. Given that TP53 mutations are consistently present in ovarian tumor samples, it is not surprising that TP53 mutations are present in the two bulk samples from PT498. Fig. 7A) . Strikingly, the TP53 mutation identified is the well-studied, relatively common This method also allowed for the establishment of precise and diverse cell phenotypic assays at very high resolution (i.e. single cell) and scale, which would increase the analytic power of experiments using limited or precious cell samples. It is especially notable that tumor cells derived from PT217 who was a chemoresistant, stage IV HGSOC patient had, by over 3-fold, the highest CA-125 serum levels of all patients in this study (1578 U/mL versus 49 U/mL for PT261, 478 U/mL for PT290 and 187 U/mL for PT317) and showed both a high CA-125 expression peak on the single-cell violin plots (Fig. 6E ) and aggressive growth kinetics (Fig. 6B) . It is clear from the CA-125 expression trends in Fig. 6E and 6F that only a subset of the cellular population exhibited this specific phenotype, which highlights the importance of a single-cell approach. The platform has the capacity to run thousands of precisely controlled experiments in parallel and measure the results rapidly, all on a single chip, providing a technical foundation upon which additional methods can be developed in order to analyze cellular heterogeneity. We envision that this type of approach could ultimately enable phenotypic screening of isolated tumor cells before the selection of the optimal patient therapy, replacing or enhancing other functional models. [32] [33] [34] Testing a tumor at the single cell level would provide insight into whether a specific targeted agent will kill all cells in the sample, and just as importantly, rule out that a prospective treatment may allow a small subset of resistant cells to survive and develop into new tumors. We believe the only way to enable such a study is to use a platform with full workflow automation such that this type of screening and analyses could be performed on thousands of cells in parallel to ensure rare populations are not missed.
Increased scale and single cell resolution of tumor cell analyses has the potential to enable more accurate assessment of phenotypic and genetic heterogeneity in HGSOC. 33, 35 Greater accuracy will also enable a better understanding of the underlying biological drivers of the disease state and hopefully enable more precise diagnosis and treatment.
This study focuses primarily on the technology and methods that demonstrate the utility of the BLI platform to interrogate intratumor heterogeneity, which supports characterization of linked single-cell phenotypic and genetic information across a culture system. Associating multifaceted phenotypic and genomic analyses will facilitate a more thorough analysis of tumor heterogeneity and could rapidly drive precision oncology development for other tumor types. Building on the conclusions from this work, future studies will focus on more detailed analyses, including cell replication with and without known chemotherapies or cellular therapies in HGSOC.
METHODS
Patient enrollment and sample collection
All blood and tumor samples were collected in accordance with the Institutional Review Board (IRB) of the Icahn School of Medicine at Mount Sinai at the time of the patient's surgery (GCO# 10-1166). Patient-derived cell lines were also generated under an IRB-approved protocol. Written informed consent was obtained from each enrolled patient prior to their debulking surgery. Samples used in this study were collected from patients over a three-year period, from 2013 to 2016. Patient PT498 was selected for our proof of concept genomics study. Standard histology and molecular analyses were carried out to determine presence of cancer, histological subtype, stage, and grade. An IRB-approved protocol was followed to review the electronic medical record for clinical information regarding CA-125 levels in sera.
Dissociation of samples and preparation for single-cell applications
Tissue containing macroscopic disease, as verified by a clinical pathologist, was obtained and placed in a 50 mL conical tube containing DMEM (Thermo Fisher Scientific, Waltham, MA #11965) supplemented with 10% FBS (ATCC, Mannassas, VA #30-2020) and 1% penicillin/streptomycin (Thermo Fisher Scientific #15140122).
Representative pieces of tissue, with grossly non-tumor containing portions excluded, ranged in size from 0.5-3.0 cm and were separated using a tissue scalpel for mechanical and enzymatic digestion. Tissue samples were processed using the GentleMACS system (Milteny Biotec, Germany #130-096-427) using the "37C_h_TDK_1"
protocol for soft human tumors as per manufacturer's recommendation. Following GentleMACS disruption, the samples were passed through 40-µm cell strainers and subjected to 15 minutes of RBC lysis using BD Lysis Buffer (BD Biosciences, Franklin Lakes, NJ #555899) diluted to a 1X concentration in sterile deionized water. Next, cells
were re-suspended in cell culture medium, stained using trypan blue for dead cell exclusion and counted using the 
Culture of human ovarian cancer cell lines
Ovarian cancer (OvCa) patient-derived cell lines (PDCLs) were developed using a ROCK inhibitor and fibroblast feeder cell system and cultured in Corning 75 cm 2 tissue culture-treated flasks. 36 Gy (3000 rad) using a cesium source irradiator prior to plating in co-culture at a ratio of 10:1. Cell lines grown using the feeder cell system were passaged once or twice in these conditions until a tumor majority was observed, at which time a portion were transferred from the feeder cell system and into feeder-cell conditioned medium. Feeder cellconditioned medium was prepared in bulk when cell line development was considered complete, at which point cell lines were independent of the feeder system, free of stromal cells and determined to maintain known patient tumor mutations.
Preparation of cell suspensions for penning
Conditioned medium was prepared as described. 36, 37 Irradiated feeder cells (1.0 × 10 7 to 1.5 × 10 7 ) were plated in 175-cm 2 tissue culture flasks in 30 mL of F medium. The medium was collected 3 days later and centrifuged at 1000
× g for 5 min at 4°C. The resulting supernatant was passed through a 0.22-µm pore-size Millex-GP filter unit (EMD Millipore, Billerica, MA #SLGP033RS). Conditioned F medium was frozen and stored at -80°C. Three volumes of conditioned F medium were mixed with one volume of fresh F medium; this mixture was supplemented with 5 µmol/L ROCK inhibitor before use.
Isolation of mononuclear cells from whole blood
Human peripheral blood mononuclear cells (PBMCs) were isolated from 10 mL of whole blood using Histopaque 
Machine vision algorithms for automated cell characterization
Images were acquired in the desired channels every 2 hours and a BLI-proprietary algorithm was used to automatically detect and count cells by pen. Moreover, this algorithm was also used to measure cell size, X,Ycoordinates and fluorescence intensity by pen.
Characterization of cell growth and protein expression
For all cell culture, BLI chips were primed using fresh or conditioned media pre-buffered with 5% CO 2 for 1 hour.
Cells from a non-adherent hybridoma cell line (OKT3) were seeded at 2x10 6 /mL in 200 µL in a 96-well plate and OEP-loaded into pens as single cells. CO 2 -buffered media was perfused through the chip at 0.01 µL/sec. Images were taken to track growth at distinct time points.
For primary cell growth assessment and automated counting, cells were pre-stained with the Syto24 (Thermo Fisher Scientific #S7559), a live cell nuclear stain, prior to loading in order to enable accurate cell counting of adherent cells. For pre-staining, cells were incubated for 15 min at room temperature in conditioned media containing a 1:30,000 dilution of Syto24 (to minimize viability impact) and 1:100 priming additive (Berkeley Lights Inc. #520-00002). Cells were re-suspended at 5-10x10 6 cells/mL in 30 µL of conditioned media. Cells were loaded onto the BLI chip at 25°C and bulk-penned using a waveform generator peak-to-peak (WFG PTP) voltage of 2.1 V at 5 µm/s, targeting 6-10 cells per pen. Each cell line was loaded into the pens of a specific region of the chip followed by image capture in brightfield (50 ms) and FITC channels (200 ms). Cross-contamination between cell lines was estimated to be non-existent by visual inspection. Cells were then cultured at 37 o C in 5% CO 2 -buffered conditioned media containing 1:100 bovine fibronectin (Sigma-Aldrich #F1141), which was perfused at 0.01 µL/s. After 24 hours, the perfusion media was switched to 5% CO 2 -buffered conditioned media without fibronectin and the bulk media was replaced every 48 hrs. Cells were cultured on the chip for a total of 6 days with image acquisition every 2 hours (exposure time of 50 ms).
To assess expression of CA-125, surface expression levels were measured by importing a dilution of 1:5 CA-125 primary antibody (Clone M11, Thermo Fisher Scientific #MA5-12425) in conditioned cell culture media, followed by incubation of 60 minutes to allow diffusion of the antibody into the pens. The unbound primary was flushed out of the chip with 250 µL of media at 1 µL/sec. Next, goat anti-mouse secondary antibody conjugated with TxRed dye at 1:100 dilution in cell culture media was imported, followed by a 60 min incubation to allow diffusion of the secondary antibody into the pens. Finally, additional Syto24 dye, diluted 1:100, was loaded and incubated for 30 min to enable staining of cell nuclei. Brightfield and fluorescent images (FITC 200 ms; TxRED 7500 ms) were captured and analyzed to obtain protein expression levels for each pen and cell.
Microscopy image processing and analysis:
Aligned images stacks of Brightfield, FITC (Syto24) and Texas Red (CA-125) channels over all fields of view were generated. Within each pen, the ImageJ multipoint selection tool was used to select each cell identified by Syto24 staining in the FITC channel. The grey value for these selections was also measured on the associated Texas Red image in the stack, yielding CA-125 fluorescence values for each cell, organized by pen. This data was then plotted in Matlab to generate the heat maps and violin plots shown.
Single cell Whole Genome Amplification (WGA)
Plate set-up and storage
Cell sorting was performed using the Single Cell Analysis and Genomic (SCAG) tool and samples were exported Upon thawing, the entire plate was simultaneously processed in order to avoid multiple freeze-thaw cycles and to prevent any DNA damage. Half of the bulk sample was processed for DNA extraction, using the PureLink Genomic DNA Mini Kit (Thermo Fisher Scientific #K182001) and subsequently purified with 1X Ampure XP beads to concentrate the sample. Whole genome amplification (WGA) was performed using molecular displacement amplification (MDA) on the remaining samples as described below.
Single Cell WGA
WGA was performed using the QIAgen REPLI-g Single Cell Kit (QIAgen, Germantown, MD #150345) MDA method, according to the manufacturer's instructions. Briefly, Buffer DLB was reconstituted with 500 µl nuclease free H 2 O and mixed well; and Lysis buffer D2 was prepared for 12 reactions using 3 µL (1M) DTT and 33 µL
Reconstituted Buffer DLB. Lysis buffer D2 preparation was scaled according to the number of reactions needed. To bring samples up to the appropriate volume, 2 µL of phospho-buffered saline (PBS) was added to each sample, for a total volume of 4 µL. Next, 3 µL of Lysis Buffer D2 was added to each sample and the contents were mixed by pipetting and briefly centrifuged. This lysis step was incubated on a thermocycler set at 65° for 10 minutes, and then 3 µL of stop solution was added to each sample, mixed, centrifuged briefly, and placed on ice. Immediately following this, 40 µL of WGA Master Mix, which included 9 µL nuclease-free water, 29 µL REPLI-g reaction buffer, and 2 µL REPLI-g sc DNA polymerase per reaction, was added to each sample and mixed by pipetting. The WGA reactions were incubated at 30°C for 8 hours. The REPLI-g DNA Polymerase was then heat inactivated at 65°C for 3 minutes.
WGA product purification
After WGA chemistry was completed and polymerase inactivated, a 1X AMPure bead-based purification was performed on the amplification products. Briefly, 50 µL of beads were added to each WGA reaction and incubated at room temperature while shaking on a vortex mixer at 2000 rpm for 10 min. The reactions were then placed on a magnetic separation device for 5 minutes or until solution was clear, at which point the supernatant was removed and discarded. While the tubes remained on the magnetic separation device, the beads were washed twice with 100 µl 80% ethanol. Without disturbing the beads, this wash solution was carefully removed and discarded. Following the wash the beads were briefly centrifuged to collect any residual ethanol from the tube walls, which was then removed and discarded. The reactions were removed from the magnet and the beads air-dried for 2 minutes. 55 µL of Elution Buffer (EB) was added to each reaction and mixed thoroughly to re-suspend the beads. The reactions were vortexed at 2000 rpm at room temperature for 2 min. Following mixing, each tube was spun down and placed on the magnetic separation device for 1 min or until the solution was completely clear. The eluate was removed and stored in a clean tube. The quantity and the quality of each WGA reaction product was determined using the DNA Broad Range Qubit Assay (Thermo Fisher Scientific #Q32853) and the 2100 Bioanalyzer, using the DNA 12000 kit (Agilent, Santa Clara, CA #5067-1508), respectively. Expected yield for each reaction was between 400-900 ng/µL.
Samples were diluted to 10 ng/µL in EB and submitted for sequencing on the Ion Torrent platform. Multiple WGA technologies were assessed for false positive and negative rate, relative to the Qiagen Repli-g kit and deemed less efficient and more error prone, relative to Repli-g (data not shown).
Ion Torrent library preparation and sequencing
Library Preparation
The 
Priming the Ion Torrent sequencing chip
Following quantification, all samples were individually normalized to 100 pMol and 2 µl of each normalized library were combined to form a pool of 96 uniquely barcoded samples at a final concentration of 100 pMol. 25 µl of this pool was used for priming the sequencing chip. Ion Torrent chip priming and sequencing were carried out using the Ion Torrent S5XL system and the Ion Chef instrument with reagents from the Ion 540 Kit-Chef (Thermo Fisher Scientific #A27759). Briefly, the Chef was used to bind each library DNA fragment to Ion Sphere Particles (ISPs) and clonally amplify each fragment by emulsion PCR. Amplified DNA fragments were then bound to streptavidincoated beads and template negative ISPs were washed away. Template-bound ISPs were then prepared for sequencing by loading onto one Ion Torrent S5 540 chip for sequencing on the Ion S5XL sequencing system.
Sequencing on the Ion Torrent Platform
The primed 540 chip was sequenced on the Ion Torrent S5 TM XL System with library read length set at 200 bp and 520 flows per chip, with all other instrument settings set to the manufacturer's default for the Ion 540 Kit. Analyses of sequencing raw data were performed with Ion Torrent Suite (version 5.0.2) using the "coverageanalysis" and "variantcaller" plugins (with somatic/low stringency settings for the "variantcaller"), with all other settings for the run report set to the manufacturer's default.
Single cell genetics data analysis
Filtering of sequencing data
Raw reads were aligned to the hg19 reference human genome using tmap on Torrent Suite (TS). Only samples with ≥300X coverage, an on target value ≥90% and a uniformity ≥60% were further analyzed. Using these very stringent criteria, 51 of 70 single cell samples, 4 of 8 10-cell samples, 7 of 8 100-cell samples and 8 of 8 1000-cell samples were used for our analyses from PT498. In addition to the various cell pools, DNA extracted from bulk cells exported from the BLI instrument acted as a positive control.
Variant calling and filtering for bulk sample control analysis
Variants were called using the variant caller plug-in from the Torrent Suite™ (Thermo Fisher Scientific) version 5.0.4 using default settings. In addition to standard homozygous and heterozygous variant calls, Torrent Suite also reported "Absent" and "No call" results for variants of interest from the targeted Hotspot panel. Variants present in ≥ 50% of each of the 10-, 100-, 1000-cell pools were used to create Virtual Bulk (VB) variants for each of the pools.
VB variants of each pool were compared to the variants identified in the single cells. If a VB variant was also found in the single cell group at a frequency < 10%, this variant was filtered out, as it was more likely to have been introduced during WGA. In one instance, a FBXW7 variant (in red) was found in three pools was filtered out, as it was only observed at a frequency of <5% in the single cell samples. For the single cell group, variants present at ≥ 20/51 samples were categorized as VB variants.
Clustering of variants and cells with intra-single cell comparison
Variant frequencies for all samples, used in the analyses, for 9 genes were supplied to the heatmap.2 function in R (v 3.3.1) to generate the heatmap. Distance matrix was computed using dist() function in R ( v 3.3.1). Variant frequencies for all samples, used in the analyses, for 9 genes were supplied to the corrplot() function in R (v 3.3.1).
Variants and cells were distributed and clustered using a complete-linkage clustering algorithm, which was implemented as a standard function (hclust) in R.
Data availability
All data that support the findings of this study are available from the corresponding author upon reasonable request.
